Highlights
1 patentProfile claimed by owner
About
Cannabis-based Cancer Treatment
MedC Biopharma is a clinical-stage company developing a novel treatment for cutaneous T-cell lymphoma, a type of skin cancer that afflicts 100,000 new patients annually. The company's R&D is based on a combined effort of Professor Hinanit Koltai, the head of medical cannabis research at the national lab in ARO, Israel, and Professor Emmilia Hodek, director of Dermatology, Rabin Medical Center, Israel. The company's R&D pipeline includes two additional skin oncology indications and anxiety-related indications.
Identity
| Name | MedC Biopharma |
|---|---|
| Slug | medc-biopharma |
| Type / kind | startup |
| Crunchbase ID | medc-biopharma |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4KbtkIULDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Mar 2023 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Rishon LeTsiyon |
| HQ address | HaRav Neriya Street 4, Rishon LeTsiyon, Israel |
Web & social
| https://www.linkedin.com/company/17970483 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical Cannabis
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business models
B2B
Tags
treatmentscancermedical-cannabisoncologypharmaceuticalscannabisrare-diseasesskin-caredrug-developmenttopical-treatment
Funding
| Total raised | $5.0M |
|---|---|
| Current stage | Series A |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}